Cipher Pharmaceuticals Management
Management criteria checks 2/4
Cipher Pharmaceuticals' CEO is Craig Mull, appointed in Jul 2019, has a tenure of 4.75 years. directly owns 2.98% of the company’s shares, worth €4.18M. The average tenure of the management team and the board of directors is 3.5 years and 3 years respectively.
Key information
Craig Mull
Chief executive officer
US$567.6k
Total compensation
CEO salary percentage | n/a |
CEO tenure | 4.8yrs |
CEO ownership | 3.0% |
Management average tenure | 3.5yrs |
Board average tenure | 3yrs |
Recent management updates
Recent updates
CEO
Craig Mull
4.8yrs
Tenure
US$567,581
Compensation
Mr. Craig J. Mull has been Chairman of the Board of Directors at Cipher Pharmaceuticals Inc. since June 11, 2019 and its Interim Chief Executive Officer since July 29, 2019, served as its President. Mr. Mu...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Interim CEO & Chairman of the Board | 4.8yrs | US$567.58k | 2.98% $ 4.2m | |
Chief Financial Officer | 1.7yrs | US$438.28k | 0.021% $ 29.1k | |
Vice President of Scientific & Medical Affairs | 5.8yrs | US$322.57k | 0.35% $ 488.8k | |
Director of Sales & Marketing | 2.3yrs | no data | no data |
3.5yrs
Average Tenure
Experienced Management: PHE's management team is considered experienced (3.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Interim CEO & Chairman of the Board | 5.1yrs | US$567.58k | 2.98% $ 4.2m | |
Lead Independent Director | 7.7yrs | US$60.85k | 1.51% $ 2.1m | |
Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data |
3.0yrs
Average Tenure
Experienced Board: PHE's board of directors are not considered experienced ( 3 years average tenure), which suggests a new board.